Bonnie Gould Rothberg

• Benjamin L. Judson
• Cary Gross
• Elizabeth Horn Prsic
• Hari Deshpande
• Jensa Morris
• Jill Lacy
• Kerin Adelson
• Maureen Canavan
• Stephan Ariyan

Epidemiology; Medical Oncology; Quality Control; Hospitalists

Cancer; Health Care Quality, Efficiency

• The impact of oncology hospitalist utilization on resident education.Bhatt S, Yao J, Gould Rothberg B, Morris J, Parker N, Adelson K, Prsic E. The impact of oncology hospitalist utilization on resident education. Journal Of Clinical Oncology 2023, 41: 11034-11034. DOI: 10.1200/jco.2023.41.16_suppl.11034.
• Impact of an oncology urgent care clinic on emergency department rates.Sedghi T, Canavan M, Gross C, Davidoff A, Gould Rothberg B, Strait M, Sinanis N, Adelson K. Impact of an oncology urgent care clinic on emergency department rates. Journal Of Clinical Oncology 2019, 37: 6615-6615. DOI: 10.1200/jco.2019.37.15_suppl.6615.
• Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs).Zhu M, Halfdanarson T, Gould Rothberg B. Meta-analysis of prognostic biomarkers for pancreatic neuroendocrine tumors (PNETs). Journal Of Clinical Oncology 2019, 37: e15688-e15688. DOI: 10.1200/jco.2019.37.15_suppl.e15688.
• Survivorship Care for Older Adults With Cancer: The Role of Primary Care Physicians and Utility of Care Plans as a Communication ToolBellizzi K, Gould Rothberg B. Survivorship Care for Older Adults With Cancer: The Role of Primary Care Physicians and Utility of Care Plans as a Communication Tool. 2017 DOI: 10.1891/9781617052828.0030.
• Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy.Jackson L, Bulloch K, Narayan D, Ariyan S, Gould Rothberg B. Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy. Journal Of Clinical Oncology 2016, 34: 172-172. DOI: 10.1200/jco.2016.34.3_suppl.172.
• The Yale Gastrointestinal Cancer Biorepository: A comprehensive biospecimen and data resource for studying determinants of pancreatic ductal adenocarcinoma prognosis following curative-intent pancreaticoduodenectomy.Gould Rothberg B, Deminie C, Lazowski H, Gibson J, Cha C, Lacy J, Hochster H, Salem R. The Yale Gastrointestinal Cancer Biorepository: A comprehensive biospecimen and data resource for studying determinants of pancreatic ductal adenocarcinoma prognosis following curative-intent pancreaticoduodenectomy. Journal Of Clinical Oncology 2015, 33: 272-272. DOI: 10.1200/jco.2015.33.3_suppl.272.
• Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity.Maron S, Gould Rothberg B, Otremba M, Judson B, Morgensztern D. Role of adjuvant radiation in patients with squamous cell carcinomas of the oral cavity. Journal Of Clinical Oncology 2013, 31: 6042-6042. DOI: 10.1200/jco.2013.31.15_suppl.6042.
• Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes.Marrone K, Otremba M, Groisberg R, Deshpande H, Crawford F, Acevedo-Gadea C, Gould Rothberg B, Judson B, Morgensztern D. Outcomes for stage IVA squamous cell carcinoma of the oral cavity according to staging subtypes. Journal Of Clinical Oncology 2013, 31: 6076-6076. DOI: 10.1200/jco.2013.31.15_suppl.6076.
• Survival and cause of death in patients with refractory anemias.Zhang Y, Gould Rothberg B, Morgensztern D. Survival and cause of death in patients with refractory anemias. Journal Of Clinical Oncology 2013, 31: 7033-7033. DOI: 10.1200/jco.2013.31.15_suppl.7033.
• The characterization of PPARα ligand drug action in an in vivo model by comprehensive differential gene expression profilingGould Rothberg B, Sundseth S, DiPippo V, Brown P, Winegar D, Gottshalk W, Shenoy S, Rothberg J. The characterization of PPARα ligand drug action in an in vivo model by comprehensive differential gene expression profiling. Functional & Integrative Genomics 2001, 1: 294-304. PMID: 11793248, DOI: 10.1007/s101420000022.
• Differential gene expression technologies for identifying surrogate markers of drug efficacy and toxicityRininger J, DiPippo V, Gould-Rothberg B. Differential gene expression technologies for identifying surrogate markers of drug efficacy and toxicity. Drug Discovery Today 2000, 5: 560-568. PMID: 11102856, DOI: 10.1016/s1359-6446(00)01597-x.